We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+3.65%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$100M
AUM Growth
-$7.81M
Cap. Flow
-$11.3M
Cap. Flow %
-11.27%
Top 10 Hldgs %
11.69%
Holding
238
New
12
Increased
100
Reduced
117
Closed
1

Top Buys

Rank Stock Value
1
ARHS icon
Arhaus
ARHS
+$228K
2
AR icon
Antero Resources
AR
+$208K
3
MTDR icon
Matador Resources
MTDR
+$203K
4
SSTK icon
Shutterstock
SSTK
+$194K
5
EXE
Expand Energy Corp
EXE
+$188K

Top Sells

Rank Stock Value
1
ELF icon
e.l.f. Beauty
ELF
+$919K
2
GBT
Global Blood Therapeutics, Inc.
GBT
+$772K
3
CPRX
Catalyst Pharmaceutical
CPRX
+$637K
4
ENPH icon
Enphase Energy
ENPH
+$535K
5
META icon
Meta Platforms (Facebook)
META
+$528K

Sector Composition

Rank Sector Weight
1 Technology 29.49%
2 Healthcare 26.32%
3 Consumer Discretionary 12.34%
4 Industrials 8.94%
5 Financials 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LOB icon
176
Live Oak Bancshares
LOB
$1.98B
$210K 0.21%
6,510
+1,269
+24% +$45.5K
UTHR icon
177
United Therapeutics
UTHR
$25.8B
$209K 0.21%
998
-244
-20% -$54.5K
ARES icon
178
Ares Management
ARES
$28.9B
$208K 0.21%
3,361
-1,117
-25% -$78.1K
TWLO icon
179
Twilio
TWLO
$30B
$206K 0.21%
2,981
-1,114
-27% -$89K
EXAS
180
DELISTED
Exact Sciences
EXAS
$201K 0.2%
5,433
+2,612
+93% +$108K
JNPR
181
DELISTED
Juniper Networks
JNPR
$200K 0.2%
7,643
-340
-4% -$9.59K
RPAY icon
182
Repay Holdings
RPAY
$331M
$200K 0.2%
25,353
-15,519
-38% -$169K
ALLO icon
183
Allogene Therapeutics
ALLO
$649M
$196K 0.2%
19,539
+3,839
+24% +$52.2K
DOMO icon
184
Domo
DOMO
$174M
$193K 0.19%
14,111
-5,761
-29% -$151K
WRB icon
185
W.R. Berkley
WRB
$26.9B
$193K 0.19%
4,475
-1,057
-19% -$45.9K
DDOG icon
186
Datadog
DDOG
$95.4B
$191K 0.19%
2,152
-816
-27% -$82.2K
THO icon
187
Thor Industries
THO
$3.9B
$191K 0.19%
2,265
-83
-4% -$6.78K
WDAY icon
188
Workday
WDAY
$39.6B
$191K 0.19%
1,255
-446
-26% -$69.8K
AG icon
189
First Majestic Silver
AG
$7.41B
$190K 0.19%
21,040
-10,363
-33% -$77.3K
DHR icon
190
Danaher
DHR
$137B
$188K 0.19%
821
-547
-40% -$134K
APPN icon
191
Appian
APPN
$1.98B
$182K 0.18%
4,753
+846
+22% +$41K
CPRT icon
192
Copart
CPRT
$27B
$182K 0.18%
6,836
-8,344
-55% -$248K
SF
193
Stifel
SF
$12.6B
$182K 0.18%
4,361
+666
+18% +$26.2K
LAW icon
194
CS Disco
LAW
$250M
$180K 0.18%
20,923
+4,436
+27% +$80.7K
STLD icon
195
Steel Dynamics
STLD
$36B
$178K 0.18%
2,506
-600
-19% -$45.4K
AKAM icon
196
Akamai
AKAM
$16.7B
$177K 0.18%
2,202
-235
-10% -$21.4K
SEER icon
197
Seer Inc
SEER
$122M
$172K 0.17%
24,604
+1,208
+5% +$11.7K
SBNY
198
DELISTED
Signature Bank
SBNY
$165K 0.16%
1,251
-616
-33% -$112K
SDGR icon
199
Schrodinger
SDGR
$1.13B
$164K 0.16%
8,597
+137
+2% +$4.03K
WAL icon
200
Western Alliance Bancorporation
WAL
$8.79B
$163K 0.16%
2,479
-1,408
-36% -$107K
6 7
8
9 10

Similar funds

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
SCM
Segra Capital Management Palm Beach, Florida $248M AUM 65.61% 1-Year Est. Return
GWS
Greykasell Wealth Strategies Danville, California $248M AUM 22.08% 1-Year Est. Return
MC
Mount Capital London, United Kingdom $248M AUM 4.81% 1-Year Est. Return

Capital Impact Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Capital Impact Advisors held 238 positions worth $100M, down 7.2% from $108M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Capital Impact Advisors withdrew a net $11.3M in Q3 2022, closing 1 position and reducing 117 holdings. Its most notable exit was Global Blood Therapeutics, Inc., an estimated $772K position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Capital Impact Advisors opened a new position in Ginkgo Bioworks worth $118K.

  • Capital Impact Advisors's largest Q3 2022 buy was Ginkgo Bioworks: 1,374 shares worth $118K.
  • Capital Impact Advisors added most to Arhaus in Q3 2022, an estimated $228K increase.
  • Capital Impact Advisors's biggest Q3 2022 reduction was e.l.f. Beauty, cutting an estimated $919K.
  • Capital Impact Advisors fully exited Global Blood Therapeutics, Inc. in Q3 2022, selling an estimated $772K.
  • Capital Impact Advisors's ten largest holdings make up 12% of its $100M portfolio in Q3 2022.
  • Capital Impact Advisors opened 12 new positions and closed 1 in Q3 2022.
  • Capital Impact Advisors's portfolio value fell 7.2% quarter-over-quarter to $100M.

Based on Capital Impact Advisors's 13F filing for Q3 2022, filed 22 Nov 2022.